From Our Partners
Wednesday, June 29, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

DHS Awards Antibody Development Contract for Biothreat Agents

by Global Biodefense Staff
May 7, 2014
Antibody Research Immunoassays

Credit: Shutterstock

The Department of Homeland Security (DHS) recently announced intentions to award a sole source contract to Silver Lake Research Corporation (SLRC) for continued development of threat agent specific monoclonal antibodies for which current gold standards methods are not able to generate a highly specific product to support the development of rapid detection assays.

The effort is managed by the DHS Directorate of Science and Technology (S&T), Chemical and Biological Defense Division (CBD).

“SLRC has produced a group of highly specific monoclonal antibodies for use in DHS and FEDGOV assays. The technology and methods used are company proprietary and unavailable from any other source,” states the announcement. “Since the Contractor’s access to their innovative and unique intellectual property are critically necessary to perform the work; the only viable alternative for the Government would be to proceed as recommended with a sole source option and is critical to S&T/CBD that the work be completed.”

S&T CBD requires that SLRC continue and complete the work for the research, development and generation of hyper-specific monoclonal antibodies specific for bacterial and viral biothreat agents.

SLRC is based in Monravia, Calif. The company develops and manufactures innovative very high affinity antibody-based products using a proprietary immunization technology, called the Enhanced Affinity Platform, or EAP™ System.

Source: FBO.gov

From Our Partners
Tags: Chemical Detection

Related Posts

Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
Biodefense Industry News
Industry News

Tonix Pharmaceuticals Opens Advanced Development Center for Vaccine Programs

June 20, 2022
Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors
Industry News

Novavax Missed Its Global Moonshot but Is Angling to Win Over mRNA Defectors

May 26, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC